The addition of prazosin to standard triple therapy in the treatment of severe hypertension
- PMID: 7066169
- PMCID: PMC1402042
- DOI: 10.1111/j.1365-2125.1982.tb01418.x
The addition of prazosin to standard triple therapy in the treatment of severe hypertension
Abstract
1 A small dose of prazosin was added to the treatment regime of sixteen hypertensive patients poorly controlled on a combination of bendrofluazide, hydralazine and propranolol. 2 There was a significant improvement in blood pressure control in all patients at 1 month (P less than 0.01) and this was maintained at 9 months (P less than 0.02). Tolerance to prazosin was not a problem. 3 The addition of prazosin to conventional triple drug therapy produces a further useful fall in blood pressure.
Similar articles
-
Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.Lancet. 1977 Feb 5;1(8006):271-4. doi: 10.1016/s0140-6736(77)91822-0. Lancet. 1977. PMID: 64803 Clinical Trial.
-
Comparison of nifedipine, prazosin and hydralazine added to treatment of hypertensive patients uncontrolled by thiazide diuretic plus beta-blocker.Postgrad Med J. 1987 Feb;63(736):99-103. doi: 10.1136/pgmj.63.736.99. Postgrad Med J. 1987. PMID: 3671250 Free PMC article. Clinical Trial.
-
[Cross-over trial with Peripress (prazosin) and Apresolin (hydralazin), both in combination with beta-blocker].Tidsskr Nor Laegeforen. 1980 Jan 30;100(3):148-49. Tidsskr Nor Laegeforen. 1980. PMID: 6992338 Clinical Trial. Norwegian. No abstract available.
-
Prazosin: a review of clinical experience in hypertension.Ther Umsch. 1981;38 Suppl:28-32. Ther Umsch. 1981. PMID: 6122285 Review. No abstract available.
-
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.Drugs. 1977 Sep;14(3):163-97. doi: 10.2165/00003495-197714030-00002. Drugs. 1977. PMID: 143363 Review. No abstract available.
Cited by
-
Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.Drugs. 1983 Apr;25(4):339-84. doi: 10.2165/00003495-198325040-00002. Drugs. 1983. PMID: 6303744 Review.
-
Treating severe hypertension.J R Coll Physicians Lond. 1984 Jan;18(1):46-50. J R Coll Physicians Lond. 1984. PMID: 6142951 Free PMC article. Review. No abstract available.
-
The pharmacological basis for the use of alpha 1-adrenoceptor antagonists in the treatment of essential hypertension.Br J Clin Pharmacol. 1986;21 Suppl 1(Suppl 1):5S-8S. doi: 10.1111/j.1365-2125.1986.tb02847.x. Br J Clin Pharmacol. 1986. PMID: 2871856 Free PMC article.
-
Induction of Tet3-dependent Epigenetic Remodeling by Low-dose Hydralazine Attenuates Progression of Chronic Kidney Disease.EBioMedicine. 2015 Jan;2(1):19-36. doi: 10.1016/j.ebiom.2014.11.005. EBioMedicine. 2015. PMID: 25717475 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical